Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)

NCT00731445 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Z-208

Sponsor

Zeria Pharmaceutical